rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

L. Jeremy Stigall

Chief Business Officer

Company insider

Files Form 4 as: Chief Business Officer, ClearPoint Neuro.

In numbers

Trades disclosed
65
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
10 Jun 2022
Last trade
30 Jun 2026
Last filed
2 Jul 2026

Companies traded

Where they are an officer
CLPT ClearPoint NeuroOfficer · Medical Devices · last 30 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Jun 2026filed 2 Jul 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code A$21K1,781 at $11.93filing
30 Jun 2026filed 2 Jul 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code A$21K1,781 at $11.93filing
12 Mar 2026filed 16 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code M—30,995filing
12 Mar 2026filed 16 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code F$175K15,151 at $11.53filing
12 Mar 2026filed 16 Mar 2026CLPT ClearPoint Neurooption or derivative · Medical DevicesSEC FORM 4 Code M—30,995filing
12 Mar 2026filed 16 Mar 2026CLPT ClearPoint Neurooption or derivative · Medical DevicesSEC FORM 4 Code M—30,995filing
12 Mar 2026filed 16 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code M—30,995filing
12 Mar 2026filed 16 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code F$175K15,151 at $11.53filing
11 Mar 2026filed 13 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code M—8,291filing
11 Mar 2026filed 13 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code F$37K3,224 at $11.62filing
11 Mar 2026filed 13 Mar 2026CLPT ClearPoint Neurooption or derivative · Medical DevicesSEC FORM 4 Code M—8,291filing
11 Mar 2026filed 13 Mar 2026CLPT ClearPoint Neurooption or derivative · Medical DevicesSEC FORM 4 Code M—8,291filing
11 Mar 2026filed 13 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code M—8,291filing
11 Mar 2026filed 13 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code F$37K3,224 at $11.62filing
6 Mar 2026filed 10 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code M—17,778filing
6 Mar 2026filed 10 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code F$69K6,913 at $10.00filing
6 Mar 2026filed 10 Mar 2026CLPT ClearPoint Neurooption or derivative · Medical DevicesSEC FORM 4 Code M—17,778filing
6 Mar 2026filed 10 Mar 2026CLPT ClearPoint Neurooption or derivative · Medical DevicesSEC FORM 4 Code M—17,778filing
6 Mar 2026filed 10 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code M—17,778filing
6 Mar 2026filed 10 Mar 2026CLPT ClearPoint NeuroMedical DevicesSEC FORM 4 Code F$69K6,913 at $10.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Timothy T. RichardsDirector · Director at ClearPoint Neuro, filing Form 4 there in the last year
R. John FletcherDirector · Director at ClearPoint Neuro, filing Form 4 there in the last year
Joseph BurnettCEO and President · CEO and President at ClearPoint Neuro, filing Form 4 there in the last year
Danilo D'AlessandroChief Financial Officer · Chief Financial Officer at ClearPoint Neuro, filing Form 4 there in the last year
Lynnette C. FallonDirector · Director at ClearPoint Neuro, filing Form 4 there in the last year